Steven Sweeney

Steven Sweeney is an experienced executive in the biotechnology and pharmaceutical sectors. Currently serving as President and Chief Operating Officer of Aliada Therapeutics, Sweeney previously held the positions of President and CEO at Integrity Clinical Services, LLC, and Executive Vice President of Clinical Development Operations at Third Harmonic Bio, where Sweeney also served as Senior Vice President of Clinical Development Operations. Additional experience includes a role as Entrepreneur In Residence at Atlas Venture and Vice President at Rodin Therapeutics, which was later acquired by Alkermes.